Who are Adenocard's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Singulair, HALOPROGIN, Oxtriphylline, Tenoretic 100, Dulcotil, Estrobene.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/adenosine.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Adenocard — Competitive Intelligence Brief

Adenocard (ADENOSINE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Adenosine Receptor Agonist [EPC]. Area: Neuroscience.

marketed Adenosine Receptor Agonist [EPC] Adenosine receptor A3 Neuroscience Small molecule Live · refreshed every 30 min

Target snapshot

Adenocard (ADENOSINE) — Astellas Pharma.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Adenocard TARGET	ADENOSINE	Astellas Pharma	marketed	Adenosine Receptor Agonist [EPC]	Adenosine receptor A3	1989-01-01
Singulair	montelukast	Merck & Co.	marketed	Leukotriene receptor antagonist (LTRA)	Cytochrome P450 2C8, Adenosine receptor A3, Cysteinyl leukotriene receptor 2	1998-02-20
HALOPROGIN	HALOPROGIN	Westwood Squibb	marketed	haloprogin	Adenosine receptor A3	1982-01-01
Oxtriphylline	choline theophyllinate	Warner Chilcott Llc	marketed	choline theophyllinate	Adenosine receptor A3, Alkaline phosphatase, tissue-nonspecific isozyme, Adenosine receptor A1	1981-01-01
Tenoretic 100	ATENOLOL	Twi Pharms	marketed	beta-Adrenergic Blocker [EPC]	Adenosine receptor A3	1981-01-01
Dulcotil	SULOCTIDIL		marketed	suloctidil	Adenosine receptor A3, Substance-K receptor, 5-hydroxytryptamine receptor 1A	1979-01-01
Estrobene	DIETHYLSTILBESTROL	Tablicaps	marketed	Standardized Chemical Allergen [EPC]	Sodium/nucleoside cotransporter 1, 5-hydroxytryptamine receptor 6, Adenosine receptor A3	1973-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Adenosine Receptor Agonist [EPC] class)

· 2 drugs in this class
Astellas Pharma · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Adenocard — Competitive Intelligence Brief. https://druglandscape.com/ci/adenosine. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab